A comprehensive functional atlas of ALK kinase domain variants reveals resistance landscape to ALK inhibitors
{{output}}
Background: ALK gene fusions are key oncogenic drivers in cancers such as non-small cell lung cancer, where they define a molecular subtype responsive to ALK tyrosine kinase inhibitors (TKIs). However, resistance commonly arises ... ...
